—#163435

Product

Dimension Vista MULTI 2 SDIL, KD694, SMN# 10483586

FDA product code: CDZ — Radioimmunoassay, Testosterones And Dihydrotestosterone
Device class: Class 1
Medical specialty: Clinical Chemistry
510(k) numbers: K151529
Affected lot / code info: lot 7CDA79, UDI # (UDI) 008427680324177CDA7918090110483586, exp 2018-09-01; lot # 7DDA70, UDI # (UDI) 008427680324177DDA7018110110483586, exp 2018-11-01

Why it was recalled

The diluent may have an incomplete slit on the septum in the cap of the vial. A diluent cap with a defective septum has the potential to cause erroneously elevated results if a sample is autodiluted onboard the system, due to a reduced volume of diluent being pipetted from the vial.

Root cause (FDA determination)

Under Investigation by firm

Action the firm took

Notification letters were distributed 3/21/18. The letters instructed customers to: Inspect stock, discontinue use of and discard the Dimension Vista Diluent lots listed in Table 1. Please review this letter with your Medical Director. Review your inventory of these products to determine your laboratorys replacement needs and to provide information to Siemens for reporting to the authorities. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. If you have received any complaints of illness or adverse events associated with the product listed in Table 1, immediately contact your local Siemens Customer Care Center or your local Siemens Technical Support Representative. Please retain this letter with your laboratory records, and forward this letter to those who may have received this product.

Recalling firm

Firm: Siemens Healthcare Diagnostics, Inc.
Address: 500 Gbc Dr Po Box 6101, Ms 514, Newark, Delaware 19702-2466

Distribution

Distribution pattern: The products were distributed to the following US states: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. The products were distributed to Guam, Saipan, and Virgin Islands. The products were distributed to the following countries: Australia, Austria, Bahamas, Belgium, Brazil, Canada, Canary Islands, Croatia, Czech Republic, Denmark, France, Germany, Italy, Japan, Lebanon, Netherlands, Poland, Portugal, Qatar, Russian Federation, Slovakia, Slovenia, Saudi Arabia, South Korea, Spain, Switzerland, and United Arab Emirates.

Timeline

Recall initiated: 2018-03-21
Terminated: 2020-06-12
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #163435. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.